Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MAXCYTE, INC. | GENERAL COUNSEL | Common Stock | 64.2K | $204K | $3.18 | Mar 18, 2025 | Direct |
MAXCYTE, INC. | GENERAL COUNSEL | Employee Stock Option (right to buy) | 92.5K | Mar 14, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MXCT | MAXCYTE, INC. | Mar 18, 2025 | 1 | -$1.12K | 4 | Mar 20, 2025 | GENERAL COUNSEL |
MXCT | MAXCYTE, INC. | Mar 14, 2025 | 2 | $0 | 4 | Mar 18, 2025 | GENERAL COUNSEL |
MXCT | MAXCYTE, INC. | Jan 13, 2025 | 1 | -$20.3K | 4 | Jan 14, 2025 | GENERAL COUNSEL |
MXCT | MAXCYTE, INC. | Mar 15, 2024 | 2 | $0 | 4 | Mar 19, 2024 | GENERAL COUNSEL |
MXCT | MAXCYTE, INC. | Feb 22, 2024 | 0 | $0 | 3 | Mar 4, 2024 | General Counsel |